Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
<0.5
General Information
Revision date
2009-07-28
Product name
INVEGA SUSTENNA Extended Release Suspension For
Substance name
Bulk Drug Product
Product Synonyms
Paliperidone Palmitate Suspension******
supplier name
Janssen Pharmaceutica NV
Emergency telephone
+32 14 602444
Icons in SDS
Company Information
company name
Janssen Pharmaceutica NV
e-mail address of the competent person responsible for the Safety Data Sheet
RA-JANBE-SAFETYDA@JANBE.JNJ.COM
Section 2
SECTION 2: Hazards identification
Directive 1999/45/EC: Classification and labeling The product is classified and labeled in accordance with Directive 1999/45/EC***
Hazard statements
Xn - Harmful ***
Most important adverse effects
R22 - Harmful if swallowed. *** General hazard information: May cause central nervous system effects May cause cardiovascular system effects.*** Carcinogenicity rating: Johnson & Johnson: Not known. European Union: Not known
